Hari Ananthula

Hari Ananthula is a Quantitative Clinical Pharmacology Scientist at Merck, where they currently serve as Director of Quantitative Pharmacology & Pharmacometrics in the Immune/Oncology division. Hari has extensively contributed to the field since joining Merck in 2017 as a Senior Scientist, and later as Associate Principal Scientist. Their early experience includes internships at the FDA and Takeda Oncology, where they focused on quantitative pharmacology and developed pivotal models for drug development. Hari is pursuing a Ph.D. in Pharmaceutical Sciences from the University of Cincinnati, along with a B.Pharm. (Hons.) from Birla Institute of Technology and Science, Pilani.